
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
Subscribe to Eagle’s Eye View
4.7
126126 ratings
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
Subscribe to Eagle’s Eye View
130 Listeners
316 Listeners
162 Listeners
851 Listeners
480 Listeners
31 Listeners
3,340 Listeners
88 Listeners
1,097 Listeners
51 Listeners
39 Listeners
321 Listeners
415 Listeners
362 Listeners
36 Listeners